Item 5.07 Submission of Matters to a Vote of Security Holders.

The 2020 Annual Meeting of Stockholders (the "Annual Meeting") of Brainstorm Cell Therapeutics Inc. (the "Company") was held virtually via the internet on November 10, 2020 to consider and vote on the proposals set forth below each of which is described in greater detail in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on October 1, 2020. The following actions were taken at the Annual Meeting:

1. The seven nominees (listed below) for election to the Company's Board of Directors were elected to hold office until the next annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier resignation or removal, based upon the following votes:





                                  Votes    Votes                Broker
                      Votes For Withheld  Against Abstentions Non-Votes

Sankesh Abbhi 9,346,018 125,190 N/A N/A 13,053,806 Dr. Irit Arbel 8,216,058 1,255,150 N/A N/A 13,053,806 Dr. June S. Almenoff 9,360,443 110,765 N/A N/A 13,053,806 Dr. Anthony Polverino 9,046,379 424,829 N/A N/A 13,053,806 Dr. Jacob Frenkel 9,261,030 210,178 N/A N/A 13,053,806 Malcolm Taub 9,043,406 427,802 N/A N/A 13,053,806 Uri Yablonka 9,314,574 156,634 N/A N/A 13,053,806

2. The proposal to approve amendments to the Company's 2014 Stock Incentive Plan and the Company's 2014 Global Share Option Plan to increase the shared pool of shares available for issuance under the Company's current equity plans by 1,600,000 additional shares (from 4,000,000 to 5,600,000 shares) of Company Common Stock was approved, based upon the following votes:

Votes For Votes Withheld Votes Against Abstentions Broker Non-Votes 6,248,132 N/A 3,061,287 161,789 13,053,806

3. The proposal to ratify the appointment of Brightman Almagor Zohar & Co., a Firm in the Deloitte Global Network, as the Company's independent registered public accounting firm for the Company's current fiscal year was approved, based upon the following votes:

Votes For Votes Withheld Votes Against Abstentions Broker Non-Votes 22,126,237 N/A 202,261 196,516 N/A

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits



Exhibit No.  Description

104 Cover Page Interactive Data File (embedded within the Inline XBRL


             document)

© Edgar Online, source Glimpses